On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Words matter: a call for humanizing and respectful language to describe people who experience incarceration
Words matter when describing people involved in the criminal justice system because language can have a significant impact upon health, wellbeing, and access to health information and services. However, terminology used in policies, programs, and research publications is often derogatory, stigmatizing, and dehumanizing.
Drug consumption rooms: an overview of provision and evidence.
Refreshing its overview of the use of drug consumption rooms, the European Union’s drug misuse monitoring centre says the evidence still contradicts concerns that such facilities encourage drug use, delay treatment entry, or aggravate problems arising from local drug markets – finding instead that both the users and the community stand to benefit.
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study.
Based on detailed treatment records kept by the Canadian province of British Columbia, a slow taper liberally interspersed with stabilisation periods offers the best chance of sustainably withdrawing from methadone without severe relapse, but still very few manage to avoid this risk – an argument for careful consideration and informed consent before making the attempt.
Opioid harm in Australia: and comparisons between Australia and Canada
Opioid use and its associated harms is an issue of great public health interest, both within Australia and internationally. This report shows that opioid harms are an issue in both Australia and Canada.
Expecting Better
Improving Health and Rights for Pregnant Women Who Use Drugs
Taking stock: A decade of drug policy - A civil society shadow report
‘Taking stock: A decade of drug policy’ evaluates the impacts of drug policies implemented across the world over the past decade, using data from the United Nations (UN), complemented with peer-reviewed academic research and grey literature reports from civil society.
Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial
Unique trial tests what emergency doctors should do when screening identifies opioid dependence. More effective at promoting treatment and curbing opioid use than referral and brief advice was, it seems, actually initiating treatment in the form of buprenorphine maintenance.
The Role of Research in Driving Progressive Drug Policy Advocacy: Reconsidering Our Approach
Despite statements from our governments that “evidence-based policy” is a priority, “evidence” is often selectively used, or, as is regularly the case with illicit drug policy, ignored all together
NOT CRIMINALS
Underpinning a health-led approach to drug use
NATIONAL MATOD SUMMIT REPORT
Medication Assisted Treatment for Opioid Dependence (MATOD) in Australia
Share this on: